Analysis

Personalis, Inc. (PSNL) Stock Analysis

Personalis, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PSNL.

websitePSNL/analysis/PSNL

Personalis, Inc.

Personalis, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PSNL.

Stock profile

Ticker

PSNL

Asset type

Stock

Market cap

$1.10B

Sector

Health Services

Industry

Medical/Nursing Services

Currency

USD

Ticker listings

Personalis, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • PSNL primary listing
  • 04X
  • A2PLTK

Latest Personalis, Inc. news

Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits

Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection

Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types a...

Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO

Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation f...

FREMONT, Calif., May 26, 2026--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that six clinical abstracts demonstrating t...

Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monit...

Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment

Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors

FREMONT, Calif., May 13, 2026--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Se...

Research sections

Valuation

Review valuation context for Personalis, Inc..

Future growth

Review future growth context for Personalis, Inc..

Past performance

Review past performance context for Personalis, Inc..

Financial health

Review financial health context for Personalis, Inc..

Dividend

Review dividend context for Personalis, Inc..

Management

Review management context for Personalis, Inc..

Ownership

Review ownership context for Personalis, Inc..

Other information

Review other information context for Personalis, Inc..

Community

Review community context for Personalis, Inc..